WIL
ALXN

Winifred I. Li’s Alexion Pharmaceuticals ALXN Stock Holding History

Winifred I. Li’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2K Buy
10
+5
+100% +$926 ﹤0.01% 482
2014
Q3 		$1K Buy
+5
New +$821 ﹤0.01% 441

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Winifred I. Li's ALXN Position: Q4 2014 in Review

Winifred I. Li increased its Alexion Pharmaceuticals (ALXN) stake by 100% in Q4 2014, buying an estimated $926 and bringing the position to 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Winifred I. Li first reported a position in ALXN in Q3 2014 and has held it in 2 quarters since. 579 funds tracked by Wall St. Rank hold ALXN as of Q4 2014.

  • Winifred I. Li held 10 shares of Alexion Pharmaceuticals worth $2K as of Q4 2014.
  • Winifred I. Li bought 5 Alexion Pharmaceuticals shares in Q4 2014, an estimated $926.
  • Alexion Pharmaceuticals made up ﹤0.01% of Winifred I. Li's portfolio in Q4 2014, its #482 holding.
  • Winifred I. Li first reported a position in Alexion Pharmaceuticals in Q3 2014 and has held it in 2 quarters since.
  • 579 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2014.

Based on Winifred I. Li's 13F filing for Q4 2014, filed 19 Feb 2015.